323 related articles for article (PubMed ID: 24241633)
1. Network medicine: finding the links to personalized therapy.
Chen JY; Piquette-Miller M; Smith BP
Clin Pharmacol Ther; 2013 Dec; 94(6):613-6. PubMed ID: 24241633
[TBL] [Abstract][Full Text] [Related]
2. Personalized medicine: the medicine of tomorrow. Foreword.
Tremblay-Servier M
Metabolism; 2013 Jan; 62 Suppl 1():S1. PubMed ID: 23018144
[No Abstract] [Full Text] [Related]
3. Structural systems pharmacology: the role of 3D structures in next-generation drug development.
Duran-Frigola M; Mosca R; Aloy P
Chem Biol; 2013 May; 20(5):674-84. PubMed ID: 23706634
[TBL] [Abstract][Full Text] [Related]
4. Systems biology in drug discovery and development.
Berg EL
Drug Discov Today; 2014 Feb; 19(2):113-25. PubMed ID: 24120892
[TBL] [Abstract][Full Text] [Related]
5. [Network pharmacology and drug discovery].
Wang J; Li XJ
Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):241-5. PubMed ID: 22066413
[TBL] [Abstract][Full Text] [Related]
6. Systems pharmacology for drug discovery and development: paradigm shift or flash in the pan?
Vicini P; van der Graaf PH
Clin Pharmacol Ther; 2013 May; 93(5):379-81. PubMed ID: 23598453
[TBL] [Abstract][Full Text] [Related]
7. Impact of genomics on personalized cancer medicine.
Arteaga CL; Baselga J
Clin Cancer Res; 2012 Feb; 18(3):612-8. PubMed ID: 22298893
[TBL] [Abstract][Full Text] [Related]
8. Introduction to the theme "Precision medicine and prediction in pharmacology".
Insel PA; Amara SG; Blaschke TF
Annu Rev Pharmacol Toxicol; 2015; 55():11-4. PubMed ID: 25562643
[No Abstract] [Full Text] [Related]
9. Systems medicine and metabolic modelling.
Mardinoglu A; Nielsen J
J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
[TBL] [Abstract][Full Text] [Related]
10. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
11. [Personalized therapeutic targeting by exome analysis].
Lamy A; Angot E; Sabourin JC
Ann Pathol; 2012 Nov; 32(5 Suppl):S44-5. PubMed ID: 23127937
[No Abstract] [Full Text] [Related]
12. Targeted medications. New focus on companion tests.
Reinke T
Manag Care; 2012 Feb; 21(2):35-8. PubMed ID: 22393602
[No Abstract] [Full Text] [Related]
13. Systems pharmacology to predict drug toxicity: integration across levels of biological organization.
Bai JP; Abernethy DR
Annu Rev Pharmacol Toxicol; 2013; 53():451-73. PubMed ID: 23140241
[TBL] [Abstract][Full Text] [Related]
14. Trial watch: personalized medicines in late-stage development.
Milne CP; Garafalo S; Bryan C; McKiernan M
Nat Rev Drug Discov; 2014 May; 13(5):324-5. PubMed ID: 24781541
[No Abstract] [Full Text] [Related]
15. Metabolic network modeling and simulation for drug targeting and discovery.
Kim HU; Sohn SB; Lee SY
Biotechnol J; 2012 Mar; 7(3):330-42. PubMed ID: 22125297
[TBL] [Abstract][Full Text] [Related]
16. A challenging drug development process in the era of personalized medicine.
Jørgensen JT
Drug Discov Today; 2011 Oct; 16(19-20):891-7. PubMed ID: 21945860
[TBL] [Abstract][Full Text] [Related]
17. Getting personal.
Nature; 2011 May; 473(7347):253-4. PubMed ID: 21593815
[No Abstract] [Full Text] [Related]
18. The journey toward personalized cancer therapy.
Tulbah A; Chaudhri N; Al Dayel F; Akhtar M
Adv Anat Pathol; 2014 Jan; 21(1):36-43. PubMed ID: 24316909
[TBL] [Abstract][Full Text] [Related]
19. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
20. What is next for small-molecule drug discovery?
Doweyko AM; Doweyko LM
Future Med Chem; 2009 Sep; 1(6):1029-36. PubMed ID: 21425992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
